236 related articles for article (PubMed ID: 9356559)
1. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
[TBL] [Abstract][Full Text] [Related]
2. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
3. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
[TBL] [Abstract][Full Text] [Related]
4. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
Psychopharmacology (Berl); 1993; 110(3):265-72. PubMed ID: 7530376
[TBL] [Abstract][Full Text] [Related]
6. The D2 receptor occupancy profile of loxapine determined using PET.
Kapur S; Zipursky RB; Jones C; Remington GJ; Wilson AA; DaSilva J; Houle S
Neuropsychopharmacology; 1996 Dec; 15(6):562-6. PubMed ID: 8946430
[TBL] [Abstract][Full Text] [Related]
7. Do loxapine plus cyproheptadine make an atypical antipsychotic? PET analysis of their dopamine D2 and serotonin2 receptor occupancy.
Kapur S; Zipursky RB
Arch Gen Psychiatry; 1998 Jul; 55(7):666-8. PubMed ID: 9672060
[No Abstract] [Full Text] [Related]
8. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
[TBL] [Abstract][Full Text] [Related]
9. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
10. Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicality.
Natesan S; Vanderspek S; Nobrega JN; McClelland RA; Kapur S
Schizophr Res; 2005 Sep; 77(2-3):189-99. PubMed ID: 15925489
[TBL] [Abstract][Full Text] [Related]
11. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
Farde L; Nyberg S; Oxenstierna G; Nakashima Y; Halldin C; Ericsson B
J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):19S-23S. PubMed ID: 7537284
[TBL] [Abstract][Full Text] [Related]
13. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
14. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
Nyberg S; Farde L; Halldin C
Neuropsychopharmacology; 1997 Jan; 16(1):1-7. PubMed ID: 8981383
[TBL] [Abstract][Full Text] [Related]
15. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Nyberg S; Farde L; Halldin C
Psychiatry Res; 1996 Oct; 67(3):163-71. PubMed ID: 8912956
[TBL] [Abstract][Full Text] [Related]
16. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.
Singh AN; Barlas C; Singh S; Franks P; Mishra RK
J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115
[TBL] [Abstract][Full Text] [Related]
17. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.
Gefvert O; Bergström M; Långström B; Lundberg T; Lindström L; Yates R
Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016
[TBL] [Abstract][Full Text] [Related]
18. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
Nordström AL; Nyberg S; Olsson H; Farde L
Arch Gen Psychiatry; 1998 Mar; 55(3):283-4. PubMed ID: 9510228
[No Abstract] [Full Text] [Related]
20. A new framework for investigating antipsychotic action in humans: lessons from PET imaging.
Kapur S
Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
